DE60044728D1 - VERFAHREN ZUR HERSTELLUNG VON INSULINVORLäUFERN UND ANALOGEN VON INSULINVORLÄUFERN MIT VERBESSERTER FERMENTATIONSAUSBEUTE IN HEFE - Google Patents

VERFAHREN ZUR HERSTELLUNG VON INSULINVORLäUFERN UND ANALOGEN VON INSULINVORLÄUFERN MIT VERBESSERTER FERMENTATIONSAUSBEUTE IN HEFE

Info

Publication number
DE60044728D1
DE60044728D1 DE60044728T DE60044728T DE60044728D1 DE 60044728 D1 DE60044728 D1 DE 60044728D1 DE 60044728 T DE60044728 T DE 60044728T DE 60044728 T DE60044728 T DE 60044728T DE 60044728 D1 DE60044728 D1 DE 60044728D1
Authority
DE
Germany
Prior art keywords
insulin
analogs
forecasts
exports
yeast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60044728T
Other languages
English (en)
Inventor
Thomas Borglum Kjeldsen
Svend Ludvigsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of DE60044728D1 publication Critical patent/DE60044728D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60044728T 1999-12-29 2000-12-04 VERFAHREN ZUR HERSTELLUNG VON INSULINVORLäUFERN UND ANALOGEN VON INSULINVORLÄUFERN MIT VERBESSERTER FERMENTATIONSAUSBEUTE IN HEFE Expired - Lifetime DE60044728D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199901869 1999-12-29
DKPA200000443 2000-03-17
PCT/DK2000/000664 WO2001049870A1 (en) 1999-12-29 2000-12-04 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast

Publications (1)

Publication Number Publication Date
DE60044728D1 true DE60044728D1 (de) 2010-09-02

Family

ID=26066173

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60044728T Expired - Lifetime DE60044728D1 (de) 1999-12-29 2000-12-04 VERFAHREN ZUR HERSTELLUNG VON INSULINVORLäUFERN UND ANALOGEN VON INSULINVORLÄUFERN MIT VERBESSERTER FERMENTATIONSAUSBEUTE IN HEFE

Country Status (13)

Country Link
EP (1) EP1246933B1 (de)
JP (1) JP4795599B2 (de)
KR (1) KR20030004315A (de)
CN (1) CN1415019A (de)
AT (1) ATE474930T1 (de)
AU (1) AU1995701A (de)
BR (1) BR0016860A (de)
CA (1) CA2392844A1 (de)
DE (1) DE60044728D1 (de)
HU (1) HUP0301640A2 (de)
PL (1) PL356005A1 (de)
RU (1) RU2002120513A (de)
WO (1) WO2001049870A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100429981C (zh) 1999-03-16 2008-11-05 诺维信公司 干酪的生产方法
US6777207B2 (en) 1999-12-29 2004-08-17 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
US7378390B2 (en) 1999-12-29 2008-05-27 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
DE60233722D1 (de) * 2001-04-02 2009-10-29 Novo Nordisk As Insulinvorstufen und verfahren zu deren herstellung
WO2002079251A2 (en) * 2001-04-02 2002-10-10 Novo Nordisk A/S Method for making human insulin precursors
EP2325335A3 (de) * 2001-09-14 2012-01-25 Clinical Genomics Pty. Ltd Nukleinsäuremarker zur Verwendung bei der Bestimmung der Veranlagung zu Neoplasma und/oder Adenom
RU2376379C2 (ru) 2001-11-19 2009-12-20 Ново Нордиск А/С Способ получения инсулиновых соединений
WO2005054291A1 (en) 2003-12-03 2005-06-16 Novo Nordisk A/S Single-chain insulin
CN100460508C (zh) * 2004-11-03 2009-02-11 马延高 人胰岛素基因在甲醇酵母中的分泌表达方法
WO2007020256A1 (en) * 2005-08-16 2007-02-22 Novo Nordisk A/S Method for making mature insulin polypeptides
EP2069502B1 (de) 2006-09-27 2014-02-26 Novo Nordisk A/S Verfahren zur herstellung gereifter insulinpolypeptide
WO2008049711A1 (en) * 2006-10-27 2008-05-02 Novo Nordisk A/S Peptide extended insulins
CN105418755A (zh) * 2015-12-28 2016-03-23 珠海冀百康生物科技有限公司 速效胰岛素前体蛋白以及速效胰岛素的制备方法
CN115927360B (zh) * 2020-05-26 2023-07-14 北京惠之衡生物科技有限公司 密码子优化的门冬胰岛素前体基因、重组载体、基因工程菌及其应用
CN114380903B (zh) * 2021-12-28 2023-07-25 上海仁会生物制药股份有限公司 一种胰岛素或其类似物前体

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4343898A (en) 1980-02-11 1982-08-10 Novo Industri A/S Process for preparing esters of human insulin
NZ199391A (en) 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
US4546082A (en) 1982-06-17 1985-10-08 Regents Of The Univ. Of California E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
US4870008A (en) 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
US5871957A (en) 1984-05-25 1999-02-16 Zymogenetics, Inc. Stable DNA constructs
AU600885B2 (en) 1984-05-25 1990-08-30 Zymogenetics Inc. Stable DNA constructs
DK58285D0 (da) 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
DK463887D0 (da) 1987-09-07 1987-09-07 Novo Industri As Gaerleader
DK336188D0 (da) 1988-06-20 1988-06-20 Nordisk Gentofte Propeptider
DK105489D0 (da) 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid
DK300090D0 (da) 1990-12-19 1990-12-19 Novo Nordisk As Fremgangsmaade til fremstilling af leadersekvenser
DK82893D0 (da) 1993-07-08 1993-07-08 Novo Nordisk As Peptid
AU1272295A (en) 1993-12-17 1995-07-03 Novo Nordisk A/S Proinsulin-like compounds
US5639642A (en) 1994-06-16 1997-06-17 Novo Nordisk A/S Synthetic leader peptide sequences
ZA954983B (en) 1994-06-17 1996-02-14 Novo Nordisk As N-terminally extended proteins expressed in yeast
KR0150565B1 (ko) * 1995-02-15 1998-08-17 김정재 유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조방법
WO1996034882A1 (en) 1995-05-05 1996-11-07 Eli Lilly And Company Single chain insulin with high bioactivity
WO1998032867A1 (en) 1997-01-24 1998-07-30 Novo Nordisk A/S Synthetic leader peptide sequences

Also Published As

Publication number Publication date
AU1995701A (en) 2001-07-16
KR20030004315A (ko) 2003-01-14
BR0016860A (pt) 2002-10-01
RU2002120513A (ru) 2004-03-27
PL356005A1 (en) 2004-05-31
HUP0301640A2 (hu) 2003-08-28
JP2003518950A (ja) 2003-06-17
CN1415019A (zh) 2003-04-30
WO2001049870A1 (en) 2001-07-12
EP1246933B1 (de) 2010-07-21
CA2392844A1 (en) 2001-07-12
JP4795599B2 (ja) 2011-10-19
ATE474930T1 (de) 2010-08-15
EP1246933A1 (de) 2002-10-09

Similar Documents

Publication Publication Date Title
DE60044728D1 (de) VERFAHREN ZUR HERSTELLUNG VON INSULINVORLäUFERN UND ANALOGEN VON INSULINVORLÄUFERN MIT VERBESSERTER FERMENTATIONSAUSBEUTE IN HEFE
DE3583824D1 (de) Vorlaeufer des insulins, verfahren zu seiner herstellung und verfahren zur herstellung von humaninsulin aus solchen vorlaeufern des insulins.
DE50014830D1 (de) C-peptid zur verbesserten herstellung von insulin und insulinanaloga
DE69020794T2 (de) Enzymatische Entfernung einer aminoterminalen Proteinsequenz.
EP0821006A3 (de) Insulinderivate mit erhöhter Zinkbindung
DE59608521D1 (de) Verfahren zur herstellung von o-acetylserin, l-cystein und l-cystein-verwandten produkten
ATE397017T1 (de) Verfahren zur herstellung von insulinvorläufern und von analogen von insulinvorläufern
DE60233722D1 (de) Insulinvorstufen und verfahren zu deren herstellung
IL127583A0 (en) Method for the production of polypeptides
DE60226323D1 (de) Peptid und dessen kosmetische oder dermatologische verwendung zur verbesserung der haftung zwischen hautzellen
ATE47880T1 (de) Vorlaeufer eines an dem c-ende amidierten peptids und dessen herstellung.
HRP940432B1 (en) Dna sequences encoding biosynthetic insulin precursors and process for preparation of insulin
DE59108392D1 (de) Enzymatisches Verfahren zur Umwandlung von Präproinsulinen zu Insulinen
DE3781832D1 (de) C-terminal-alpha-amidierendes enzym und verfahren zu dessen herstellung und verwendung.
WO2002079251A3 (en) Method for making human insulin precursors
DE59503776D1 (de) Cyclohexapeptide und deren Mischungen, Verfahren zur Herstellung sowie deren Verwendung
EP0191869A4 (de) Fisch-kalzitoninabkömmling und dessen herstellung und gensystem dafür.